课题基金 / 基金详情

AMPK synthetic activators

AMPK synthetic activators
AMPK 合成激活剂
批准号：
10255330
负责人：
Mark Henderson
金额：
$11.24万
依托单位：
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/10255330
关键词：
5&apos-AMP-activated protein kinaseAdenosine MonophosphateAutophagocytosisBiological AssayBiologyCellsCholesterolCollaborationsDiseaseExtramural ActivitiesGoalsHomeostasisInformaticsLysosomal Storage DiseasesMass Spectrum AnalysisMeasurementMetabolismModelingPathway interactionsPharmaceutical ChemistryPhenotypeProcessProtein KinaseResearchResearch PersonnelScientistStressSynthesis ChemistryTranslationsUnited States National Institutes of HealthValidationWorkassay developmentbasedrug developmentdrug discoveryimprovedinterestlead optimizationmethyl-beta-cyclodextrinnew technologynovelresponsescreeningsmall moleculesmall molecule therapeuticstherapeutic developmenttool

项目摘要

项目成果

Mark Henderson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
During this period the team has pursued small molecules to activate 5' adenosine monophosphate-activated protein kinase (AMPK). The team has optimizing selected chemotype via medicinal chemistry efforts. AMPK activators are of interest for Niemann Pick C, a lysosomal storage disease characterized by cholesterol accumulation. The project team has developed a novel high-throughput mass spectrometry-based assay that allows direct measurement of cholesterol in relevant cells. The set of candidate AMPK activators are being assessed using the mass spectrometry assay.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Cell-Based Assay to Identify Small Molecules for Galactocerebrosidase (GALC)
Identifying small molecules with selective toxicity towards muscle invasive prostate cancer cells
Evaluation of CD206 agonists in diabetic retinopathy
Identification of small molecules that improve trafficking of NLGN4X/Y for autism
海外基金